A 50-year-old female, wit...

A 50-year-old female, with a history of obesity and diabetes for the past five years, is currently on a regimen of glimepiride 2 mg twice daily, metformin 1000 mg twice daily, and pioglitazone 15 mg once daily. Despite this combination, her HbA1c remains elevated at 8 percent. In an attempt to address the insufficient glycemic control, her treating physician introduced dapagliflozin 10 mg once daily, resulting in improved blood sugar levels for three months. However, over the past six months, the HbA1c has risen again to 7.6 percent. Kindly suggest any alternative interventions or modifications to the current treatment plan can be done with explaination.